Introduction
============

The clinical efficacy of nitinol stent implantation for the femoropopliteal arterial segment is favorable when endovascular therapy (EVT) is used to treat peripheral artery disease.^[@R1],[@R2])^ However, some problems have been reported in this segment, and these are related to both the implanted stents and the morphologic changes of the artery during limb movements.^[@R3]--[@R7])^

EVT is usually performed in the supine position on an angiographic table with the knee in extension. After stent deployment, angiography is performed to confirm the results only in knee extension; however, angiography is never performed with the knee in flexion. Therefore, morphologic changes of the artery during limb movements cannot be confirmed. It seems that these morphologic changes might potentially affect long-term results.

In this study, we performed angiography with the knee in both extension and flexion after stent deployment. Based on these images, we investigated morphologic changes of the artery during limb movements, and discussed the influences of stent implantation in the femoropopliteal arterial segment.

Methods
=======

Patients
--------

Between July 2012 and January 2015, 12 limbs were treated in 12 consecutive patients who met the following criteria: obliterative lesions in the FPAS, no severe stenosis in the popliteal artery, and one or more patent arteries in the lower leg. The age of the patients was 48--88 years (73.2±11.3 years), and all the cases were male. Based on the Trans-Atlantic Inter-Society Consensus (TASC) II classification,^[@R8])^ one case was class A, 10 were class B, and one was class C. Six cases had total occlusion in this segment. Five cases had ulcer and/or gangrene of the foot. In seven patients who had intermittent claudication, both medication and exercise therapy were attempted as initial therapy. However, since they did not show significant improvement, we decided that additional treatment was necessary.^[@R8])^

The majority of cases had risk factors for arteriosclerotic disease, such as diabetes mellitus, hypertension, hyperlipidemia, and/or smoking. Additionally, they had previous vascular treatments and/or hemodialysis due to arteriosclerosis ([**Table 1**](#table1){ref-type="table"}).

###### Table 1 Background of the patients

  Case   Age   DM   HT   HL   Smoking   CVD   CAD   HD   Previous surgery for vascular disease
  ------ ----- ---- ---- ---- --------- ----- ----- ---- ---------------------------------------
  1      88    ●    ●                                    
  2      68         ●         ●                          
  3      82    ●    ●    ●    ●         ●     ●          
  4      77         ●         ●                          
  5      68         ●         ●                     ●    
  6      65    ●    ●         ●               ●     ●    AP
  7      77         ●                               ●    DAA, AAA
  8      64    ●    ●    ●    ●               ●          AP
  9      48    ●    ●         ●               ●     ●    AP
  10     76    ●    ●    ●    ●               ●          
  11     88    ●    ●         ●               ●          
  12     77    ●    ●    ●    ●               ●          

DM: diabetes mellitus; HT: hypertension; HL: hyperlipidemia; CVD: cerebrovascular disease; CAD: coronary artery disease; HD: hemodialysis; AP: coronary artery bypass grafting for angina pectoris; DAA: total arch replacement for dissecting aortic aneurysm; AAA: bifurcated graft replacement for abdominal aortic aneurysm

EVT procedure
-------------

Since the target lesions in the femoropopliteal arterial segment were total obstruction or severe stenosis with calcification in all cases, we performed EVT with primary implantation of stents to avoid dissection and/or re-occlusion of the segment.^[@R9])^ The patients were treated in the supine position on the angiographic table. Under local anesthesia, a 6Fr vascular introducer sheath (various manufacturers) was inserted into the superficial femoral artery via the ipsilateral common femoral artery. Through the vascular introducer sheath, a 4Fr angiographic catheter (various manufacturers) was inserted over a 0.035 inch guide wire (various manufacturers). After angiography, which was performed to assess the target lesion, the guide wire was advanced to cross the lesion. In one case that had total occlusion with severe calcification, predilatation of the lesion was needed to insure passage of the stent-bearing catheter system. Due to the availability of devices in our hospital, a SMART Control™ stent (Cordis Corp., Florida, ML, USA),^[@R10])^ having stronger axial rigidity, was used for the first six cases, and a Misago™ stent (Terumo Corp., Tokyo, Japan),^[@R11])^ a more flexible stent, for the rest. The diameter and the length of stent were selected from both computed tomography (CT) and angiography images. An angioplasty balloon (various manufacturers) was used to perform post-dilatation in all cases.

After stent deployment, angiography was performed with the knee in extension by injecting contrast medium from the vascular introducer sheath. This resulted in the usual anteroposterior view of the leg. After that, angiography was performed with the knee in flexion. At that time, the ipsilateral hip joint was maintained in abduction and external rotation to keep the knee in flexion. The angle of the knee joint was set to maximal in a position that the patients could maintain without assistance, instead of a constant angle. Since we considered that maximal flexion would have the greatest influence on deformation of the artery, we used this method in each patient. The images were obtained from the inner thigh, and showed a lateral view of the leg. Angiography was performed by injecting contrast medium through the sheath, and morphologic changes of the artery with the knee in flexion were observed.

After EVT, all patients received one or more antiplatelet agents due to their previous vascular disease and/or stent implantation. We followed them for three years.

Evaluation of the stent position
--------------------------------

During the operation, based on the angiographic images and preoperative CT images, the distance from the knee joint line to the distal end of the implanted stent and the size of the artery at the distal part of the stent were measured with the knee in extension. Then, the distance from the distal end of the stent to the most proximal bending point of the femoropopliteal arterial segment was measured with the knee in flexion. By subtraction (addition in Cases 10 and 12) of these distances, the distance from the knee joint line to the most proximal bending point of the popliteal artery was calculated with the knee in extension. The bend angle of the knee joint was measured by the angle made by the intersection of the center line of the thigh bone and the tibial bone ([**Fig. 1**](#figure1){ref-type="fig"}).

![Fig. 1 Evaluation of stent position.](avd-12-2-oa.18-00162-figure01){#figure1}

This study was approved by the Ethical Committee at our institute, and informed consent was obtained from all the patients.

Results
=======

All the cases were treated by EVT without any additional procedures. One or two self-expanding nitinol stents were used, which were 40--150 mm in length and 6--7 mm in diameter. The treated length in 12 cases was 40--177 (101.5±36.4) mm. In knee extension, the distal end of the implanted stent was placed at various distances (5--10 cm in two cases, 10--15 cm in nine cases, and 15--20 cm in one case) above the level of the knee joint line. At the distal part of the stent, the diameter of the artery was 3.2--5.7 (4.6±0.6) mm on preoperative CT images. In Case 2, the diameter was 3.2 mm; however, a diameter ≥4 mm was observed in all of the other cases.

On angiography with the knee in flexion, the popliteal artery was severely bent behind the knee in all the cases with various degrees of curvature. The angle of the knee joint was 95--133 (120±11) degrees, which was anatomically close to the maximum angle of the knee joint. Although the vascular stents were implanted at several levels of the femoropopliteal arterial segment, the most proximal bending point of the artery was observed at about 10 (9.88±0.61) cm above the knee joint line in all cases ([**Fig. 2**](#figure2){ref-type="fig"}). In two cases (Cases 10 and 12) that were treated by a Misago™ stent, the distal end of the stent was placed \<10 cm above the knee joint line. However, as was observed in other cases, the most proximal bending of the artery occurred at about 10 cm above the knee joint line, and it was within the implanted stent ([**Fig. 3A**](#figure3){ref-type="fig"}).

![Fig. 2 Stent position and arterial bending.](avd-12-2-oa.18-00162-figure02){#figure2}

![Fig. 3 The morphologic changes of the artery during the limb movements.](avd-12-2-oa.18-00162-figure03){#figure3}

In this series, seven cases had only intermittent claudication. In six cases, symptoms were improved by EVT, and the patients had no symptoms for three years. However, in one case (Case 2), the treated artery was occluded during the observation period. The patient was treated with a SMART Control™ stent, which was 6 mm in diameter and 100 mm in length. On post-implant angiography, no abnormalities were observed with the knee in extension. The distal end of the stent was placed approximately 10 cm above the knee joint line. However, with the knee in flexion, kinking of the artery was observed at the distal part of the stent. It was almost the same position as the most proximal bending point of the artery ([**Fig. 3B**](#figure3){ref-type="fig"}). At 16 months after EVT, a short segment of the artery was occluded at the distal part of the stent, which was just the kinked segment. However, since the artery below the occlusion was patent, we performed femoropopliteal bypass with a vascular prosthesis.

Five patients who had ulcer and/or gangrene of the foot were included in this study. In two of these five patients, the ulcer healed after EVT; however, the other 3 died during the observation period. In one patient on dialysis, amputation below the knee was performed due to worsening gangrene after EVT; however, this patient died of acute myocardial infarction 1 month later. Another patient on dialysis was discharged after EVT and continued treatment for gangrene at another hospital. Although this patient had another amputation at 12 months after EVT due to worsening gangrene, the patient died of sepsis. In the most recent case, although the ulcer of the malleolus had completely healed after EVT, gangrene of the toe had not. Thus, minor amputation was performed at 9 months after EVT. Two years later, he died of acute myocardial infarction. There were no complications related to the implanted stents during the observation period in the three patients who had gangrene and died ([**Table 2**](#table2){ref-type="table"}).

###### Table 2 Results of endovascular therapy

  Case   TASC II class   S/O   Vascular stent (mm)   Preoperative ABI   Postoperative ABI   Fontaine class   Prognosis of the leg
  ------ --------------- ----- --------------------- ------------------ ------------------- ---------------- --------------------------
  1      B               O     S: 6×80               0.58               0.81                IV: Toe          Healing
  2      B               S     S: 6×100              Not measured       0.83                II               Occluded (F--P bypass)
  3      B               S     S: 6×100              0.84               0.94                II               Improved
  4      B               O     S: 6×100              0.53               0.99                II               Improved
  5      B               O     S: 6×80               0.65               0.77                II               Improved
  6      A               S     S: 6×40               0.6                0.73                II               Improved
  7      C               S     M: 7×100+M: 6×100     Not measured       Not performed       IV: Foot, toe    Major amputation (death)
  8      B               O     M: 6×100              0.79               0.92                II               Improved
  9      B               S     M: 6×80               0.7                0.8                 IV: Toe          Major amputation (death)
  10     B               O     M: 6×100+M: 6×40      0.64               0.85                IV: Toe          Healing
  11     B               S     M: 7×150              0.78               1.05                II               Improved
  12     B               O     M: 6×80               Not measured       0.59                IV: Heel, toe    Minor amputation (death)

TASC: Trans-Atlantic Inter-Society Consensus; S/O: stenosis/occlusion, preoperatively; M: Misago™ stent; S: SMART Control™ stent; ABI: ankle--brachial pressure index; F--P bypass: femoropopliteal bypass

Discussion
==========

The femoropopliteal arterial segment demonstrates bending, twisting, and axial compression to prevent kinking with the knee in flexion.^[@R12],[@R13])^ The superficial femoral artery tends to deform more in the bottom third than in other sections, and this is likely because of less musculoskeletal constraint distal to the adductor canal.^[@R14])^ The artery has two fixed anatomical points around the knee joint, one proximal to the adductor canal and the other distal to the origin of the anterior tibial artery. The most significant bending of the popliteal artery occurs with the knee in flexion.^[@R15])^ Diaz et al. defined the main flexion of the popliteal artery as the 'hinge point,' and this accompanies flexion as the 'accessory flexion.' Some accessory flexion occurred above or below the hinge point.^[@R12])^

Previous studies reported that if vascular stents were implanted in this segment, there could be some complications such as stent fracture, intimal hyperplasia, or vascular occlusion.^[@R3]--[@R7])^ Furthermore, Smouse et al. reported that a stent with stronger axial rigidity implanted in the femoropopliteal arterial segment results in less bending and compression of the artery in the lesion. Consequently, the artery below the stent will tend to bend more. Moreover, there is a high possibility that the artery will be kinked at the margin of the stent, leading to some problems in the artery.^[@R7])^

In the first 6 cases in this study, a SMART Control™ stent, having stronger axial rigidity, was implanted in the femoropopliteal arterial segment. In Case 2, the distal end of the stent was placed about 10 cm above the level of knee joint line. On post-implant angiography, the artery was kinked at the distal part of the stent with the knee in flexion ([**Fig. 3B**](#figure3){ref-type="fig"}). The artery was occluded at this point. In the other 5 cases, since the distal end of the stent was away from the most proximal bending point with the knee in flexion, some straight segment could be seen without kinking between the distal end of the stent and the most proximal bending point. These cases had no problems in this segment. Although it is difficult to draw conclusions based on one case, it seems that there is a possibility that early occlusion might be induced by irritation from the implanted stent when a kink of the artery occurred with the knee in flexion.

In the latter six cases, a Misago™ stent, having excellent flexibility, was implanted in the femoropopliteal arterial segment. In Cases 10 ([**Fig. 3A**](#figure3){ref-type="fig"}) and 12, the distal end of the stent was located 5--10 cm above the knee joint line due to the necessity of treatment. With the knee in flexion, a 'hinge point' and 'accessory flexion' were observed around the knee. There was a bend of the artery in the implanted stent at about 10 cm above the knee joint line. This was the most proximal bending point. As the Misago™ stent has excellent flexibility, it conformed to the bending of the artery without kinking with the knee in flexion. Over a three-year observation period, there were no problems related to treatment of this segment. However, as bending of the arteries occurred within the implanted stent, other complications might occur in the future, such as stent fracture due to the repetitive flexion of the stent.^[@R4])^

Vascular stents for peripheral arteries have various characteristics with each device. In this study, we selected two stents due to the availability of devices in our hospital. Coincidentally, they had opposite characteristics. The SMART Control™ stent has stronger axial rigidity, whereas the Misago™ stent has excellent flexibility. The arteries could be influenced by the structure of the leg as well as the characteristics of the implanted stent.^[@R12],[@R13])^ We were not able to implant these stents in the same arterial segment in each patient for a comparative trial. However, from this study, we believe that stents with stronger axial rigidity (such as SMART Control™) would be useful in a straight segment of the femoropopliteal arterial segment even in knee flexion, whereas stents with excellent flexibility (such as Misago™) would be useful in parts of the femoropopliteal arterial segment that bend with knee flexion. To prevent some complications, it seems important to select the stent according to the conditions of the treated arterial segment during limb movement. From our cases, it seems that flexible stents should be chosen for cases in which the distal edge of the stent is \<10 cm above the knee joint line.

Miki et al. reported that a small vessel is an indicator of high-risk target lesion revascularization with stent implantation in superficial femoral artery lesions.^[@R16])^ In Case 2, after considering the occluded pattern, we suspected that the most probable cause of the occlusion was kinking of the artery. However, the small arterial diameter at the distal part of the stent could have secondarily affected the occlusion. According to the device labeling of these two stents, the stents should be implanted in arteries with diameters \>4 mm for safety. In our series, only this case had an arterial diameter \<4 mm. On preoperative CT, the diameter of the artery at the distal part of the stent was 3.2 mm. However, in all the other cases, the arterial diameter was \>4 mm. It seems that a small diameter at the distal part of the stent might easily induce kinking and occlusion of the artery. Therefore, we believe that, for the selection of the distal position of the stent, the size of the artery should also be considered.

In this report, we have discussed morphologic changes of the femoropopliteal arterial segment due to limb movements after EVT, and the relevance of the position and size of the artery and characteristics of the stent. Moreover, in the literature, calcification of the artery also influences arterial deformation with the knee in flexion.^[@R17])^ When a stent with strong axial rigidity is in contact with a calcified artery, the artery might be likely to kink easily with the knee in flexion. From this point of view, it seems that the distal end of the stent should not be placed at the proximal side of a severely calcified lesion in this segment. In our series, calcification of the artery was not a problem, since there were no cases with severe calcification of the artery at the distal side of the stent.

In this study, we performed angiography with the knee in both extension and flexion for all cases. It was difficult to predict morphologic changes of the artery during limb movements based only on the image before stent implantation with the knee in extension. Although the image after stent implantation with the knee in flexion is not necessary for all cases, it seems that it might be useful for predicting some complications in the future. Based on the image with the knee in flexion, cases that show kinking of the artery at the distal side of the stent should be observed carefully. Moreover, if the injected contrast medium is delayed or stopped due to kinking of the artery, additional procedures would be required to avoid early occlusion.

A limitation of this study is there were a small number of cases and a short follow-up period. Furthermore, to give priority to observation of the morphologic changes of the femoropopliteal arterial segment, we included patients with claudication or critical limb ischemia. Outcomes would have been expected to be different in these two groups. In this study, three out of five cases of critical limb ischemia died during the observation period. We were unable to evaluate the arterial conditions during 3 years due to the death of some patients and the inability to perform the image examination of some cases without occlusion. In the future, we will investigate patency and restenosis rates, amputation-free survival and other endpoints for each stent, with a special focus on the claudication group. Then, we would like to consider how to place a stent in this segment that would not show dangerous morphologic changes from extension to flexion.

Conclusion
==========

To prevent complications in EVT of the femoropopliteal arterial segment, it is important to consider the characteristics and position of the stent, which adapt to the morphology and deformation of the artery during limb movements.
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